• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初次脑脊液分流感染后的再次感染。

Reinfection following initial cerebrospinal fluid shunt infection.

作者信息

Simon Tamara D, Hall Matthew, Dean J Michael, Kestle John R W, Riva-Cambrin Jay

机构信息

Division of Inpatient Medicine, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.

出版信息

J Neurosurg Pediatr. 2010 Sep;6(3):277-85. doi: 10.3171/2010.5.PEDS09457.

DOI:10.3171/2010.5.PEDS09457
PMID:20809713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2953872/
Abstract

OBJECT

Significant variation exists in the surgical and medical management of CSF shunt infection. The objectives of this study were to determine CSF shunt reinfection rates following initial CSF shunt infection in a large patient cohort and to determine management, patient, hospital, and surgeon factors associated with CSF shunt reinfection.

METHODS

This retrospective cohort study included children who were in the Pediatric Health Information System (PHIS) database, who ranged in age from 0 to 18 years, and who underwent uncomplicated initial CSF shunt placement in addition to treatment for initial CSF shunt infection between January 1, 2001, and December 31, 2008. The outcome was CSF shunt reinfection within 6 months. The main predictor variable of interest was surgical approach to treatment of first infection, which was determined for 483 patients. Covariates included patient, hospital, surgeon, and other management factors.

RESULTS

The PHIS database includes 675 children with initial CSF shunt infection. Surgical approach to treatment of the initial CSF shunt infection was determined for 483 children (71.6%). The surgical approach was primarily shunt removal/new shunt placement (in 286 children [59.2%]), but a substantial number underwent externalization (59 children [12.2%]), of whom a subset went on to have the externalized shunt removed and a new shunt placed (17 children [3.5% overall]). Other approaches included nonsurgical management (64 children [13.3%]) and complete shunt removal without shunt replacement (74 children [15.3%]). The 6-month reinfection rate was 14.8% (100 of 675 patients). The median time from infection to reinfection was 21 days (interquartile range [IQR] 5-58 days). Children with reinfection had less time between shunt placement and initial infection (median 50 vs 79 days, p = 0.06). No differences between those with and without reinfection were seen in patient factors (patient age at either shunt placement or initial infection, sex, race/ethnicity, payer, indication for shunt, number of comorbidities, distal shunt location, and number of shunt revisions at first infection); hospital volume; surgeon volume; or other management factors (for example, duration of intravenous antibiotic use). Nonsurgical management was associated with reinfection, and complete shunt removal was negatively associated with reinfection. However, reinfection rates did not differ between the 2 most common surgical approaches: shunt removal/new shunt placement (44 [15.4%] of 286; 95% CI 11.4%-20.1%) and externalization (total 12 [20.3%] of 59; 95% CI 11.0%-32.8%). Externalization followed by shunt removal/new shunt placement (5 [29.4%] of 17; 95% CI 10.3%-56.0%) and nonsurgical management (15 [23.4%] of 64; 95% CI 13.8%-35.7%) had higher, but nonstatistically significant, reinfection rates. The length of stay was shorter for nonsurgical management.

CONCLUSIONS

Surgical approach to treatment of initial CSF shunt infection was not associated with reinfection in this large cohort of patients.

摘要

目的

脑脊液分流感染的手术和药物治疗存在显著差异。本研究的目的是确定一大群患者初次脑脊液分流感染后的脑脊液分流再感染率,并确定与脑脊液分流再感染相关的治疗、患者、医院和外科医生因素。

方法

这项回顾性队列研究纳入了儿科健康信息系统(PHIS)数据库中的儿童,年龄在0至18岁之间,他们在2001年1月1日至2008年12月31日期间除接受初次脑脊液分流感染治疗外,还接受了无并发症的初次脑脊液分流置管。结局指标是6个月内的脑脊液分流再感染。主要的预测变量是首次感染的手术治疗方法,对483例患者进行了评估。协变量包括患者、医院、外科医生和其他治疗因素。

结果

PHIS数据库包括675例初次脑脊液分流感染的儿童。确定了483例儿童(71.6%)初次脑脊液分流感染的手术治疗方法。手术方法主要是分流器移除/新分流器置入(286例儿童[59.2%]),但有相当数量的儿童接受了外置引流(59例儿童[12.2%]),其中一部分随后进行了外置分流器移除和新分流器置入(17例儿童[总体3.5%])。其他方法包括非手术治疗(64例儿童[13.3%])和完全移除分流器而不更换分流器(74例儿童[15.3%])。6个月再感染率为14.8%(675例患者中的100例)。从感染到再感染的中位时间为21天(四分位间距[IQR]5 - 58天)。再感染儿童在分流置管和初次感染之间的时间较短(中位时间50天对79天,p = 0.06)。在患者因素(分流置管或初次感染时的患者年龄、性别、种族/民族、付款人、分流指征、合并症数量、远端分流位置以及首次感染时分流器修订次数)、医院量、外科医生量或其他治疗因素(例如静脉使用抗生素的持续时间)方面,再感染组和未再感染组之间没有差异。非手术治疗与再感染相关,完全移除分流器与再感染呈负相关。然而,两种最常见的手术方法之间的再感染率没有差异:分流器移除/新分流器置入(286例中的44例[15.4%];95%CI 11.4% - 20.1%)和外置引流(59例中的12例[20.3%];95%CI 11.0% - 32.8%)。外置引流后进行分流器移除/新分流器置入(17例中的5例[29.4%];95%CI 10.3% - 56.0%)和非手术治疗(64例中的15例[23.4%];95%CI 13.8% - 35.7%)的再感染率较高,但无统计学意义。非手术治疗的住院时间较短。

结论

在这个大型患者队列中,初次脑脊液分流感染的手术治疗方法与再感染无关。

相似文献

1
Reinfection following initial cerebrospinal fluid shunt infection.初次脑脊液分流感染后的再次感染。
J Neurosurg Pediatr. 2010 Sep;6(3):277-85. doi: 10.3171/2010.5.PEDS09457.
2
Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.首次脑脊液分流感染治疗后的再感染:一项前瞻性观察队列研究。
J Neurosurg Pediatr. 2018 Apr;21(4):346-358. doi: 10.3171/2017.9.PEDS17112. Epub 2018 Feb 2.
3
Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.美国各儿科医院初次脑脊液分流术后的感染率。临床文章。
J Neurosurg Pediatr. 2009 Aug;4(2):156-65. doi: 10.3171/2009.3.PEDS08215.
4
Management of shunt infections: a multicenter pilot study.分流感染的管理:一项多中心试点研究。
J Neurosurg. 2006 Sep;105(3 Suppl):177-81. doi: 10.3171/ped.2006.105.3.177.
5
Association of intraventricular hemorrhage secondary to prematurity with cerebrospinal fluid shunt surgery in the first year following initial shunt placement.早产继发脑室内出血与首次放置分流管后第一年脑脊液分流手术的关联。
J Neurosurg Pediatr. 2012 Jan;9(1):54-63. doi: 10.3171/2011.10.PEDS11307.
6
Role of endoscopic third ventriculostomy at infected cerebrospinal fluid shunt removal.内镜下第三脑室造瘘术在感染性脑脊液分流管移除中的作用。
J Neurosurg Pediatr. 2012 Mar;9(3):320-6. doi: 10.3171/2011.12.PEDS11229.
7
Few Patient, Treatment, and Diagnostic or Microbiological Factors, Except Complications and Intermittent Negative Cerebrospinal Fluid (CSF) Cultures During First CSF Shunt Infection, Are Associated With Reinfection.除首次脑脊液分流感染期间的并发症和间歇性脑脊液(CSF)培养阴性外,很少有患者、治疗以及诊断或微生物学因素与再感染相关。
J Pediatric Infect Dis Soc. 2014 Mar;3(1):15-22. doi: 10.1093/jpids/pit050. Epub 2013 Aug 26.
8
Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.首次脑脊液分流感染管理的变异性:一项前瞻性多机构观察队列研究
J Pediatr. 2016 Dec;179:185-191.e2. doi: 10.1016/j.jpeds.2016.08.094. Epub 2016 Sep 28.
9
Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery.抗生素浸渍导管和鞘内抗生素用于预防儿童低风险脑积水分流术相关的脑脊液分流感染。
BMC Pediatr. 2024 May 11;24(1):325. doi: 10.1186/s12887-024-04798-9.
10
Association of cerebrospinal fluid parameters with treatment and complications among children with cerebrospinal fluid shunt infections: a multicenter study.脑脊髓液参数与脑脊髓液分流感染患儿治疗和并发症的相关性:一项多中心研究。
J Neurosurg Pediatr. 2023 Oct 13;33(1):35-43. doi: 10.3171/2023.8.PEDS23348. Print 2024 Jan 1.

引用本文的文献

1
Probabilistic Graphical Models for Evaluating the Utility of Data-Driven ICD Code Categories in Pediatric Sepsis.用于评估数据驱动的儿科脓毒症ICD编码类别的效用的概率图模型
AMIA Annu Symp Proc. 2025 May 22;2024:1149-1158. eCollection 2024.
2
Management of Recurrent Ventriculoperitoneal Shunt Infections in Adult Patients.成人复发性脑室腹腔分流感染的管理
Antibiotics (Basel). 2025 Jan 13;14(1):77. doi: 10.3390/antibiotics14010077.
3
A search for bacteria identified from cerebrospinal fluid shunt infections in previous surgical events.

本文引用的文献

1
Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.美国各儿科医院初次脑脊液分流术后的感染率。临床文章。
J Neurosurg Pediatr. 2009 Aug;4(2):156-65. doi: 10.3171/2009.3.PEDS08215.
2
Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop.脑积水研究的优先事项:美国国立卫生研究院主办研讨会的报告
J Neurosurg. 2007 Nov;107(5 Suppl):345-57. doi: 10.3171/PED-07/11/345.
3
Hospital care for children with hydrocephalus in the United States: utilization, charges, comorbidities, and deaths.
检索从前手术事件中脑脊液分流感染所分离出的细菌。
PLoS One. 2024 Oct 10;19(10):e0311605. doi: 10.1371/journal.pone.0311605. eCollection 2024.
4
Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery.抗生素浸渍导管和鞘内抗生素用于预防儿童低风险脑积水分流术相关的脑脊液分流感染。
BMC Pediatr. 2024 May 11;24(1):325. doi: 10.1186/s12887-024-04798-9.
5
Implementation of an adapted perioperative ventriculoperitoneal shunting protocol in a tertiary center located in a low-to-middle-income country.在一个中低收入国家的三级中心实施一种改良的围手术期脑室腹腔分流术方案。
Childs Nerv Syst. 2024 Jun;40(6):1839-1847. doi: 10.1007/s00381-024-06374-z. Epub 2024 Apr 1.
6
Associations of Standard Care, Intrathecal Antibiotics, and Antibiotic-Impregnated Catheters With Cerebrospinal Fluid Shunt Infection Organisms and Resistance.标准治疗、鞘内抗生素和抗生素浸渍导管与脑脊液分流感染病原体和耐药性的关联。
J Pediatric Infect Dis Soc. 2023 Sep 27;12(9):504-512. doi: 10.1093/jpids/piad064.
7
Novel concepts in the pathogenesis of hydrocephalus.脑积水发病机制的新观念。
Childs Nerv Syst. 2023 May;39(5):1245-1252. doi: 10.1007/s00381-023-05891-7. Epub 2023 Feb 27.
8
Correlation between cerebrospinal fluid abnormalities before ventriculoperitoneal shunt and postoperative intracranial infection in adult patients with hydrocephalus: A clinical study.成人脑积水患者脑室腹腔分流术前脑脊液异常与术后颅内感染的相关性:一项临床研究
Front Neurol. 2023 Jan 24;13:1023761. doi: 10.3389/fneur.2022.1023761. eCollection 2022.
9
External ventricular drainage: indications and outcome among Sudanese Children.体外脑室引流:苏丹儿童的适应症及治疗结果
Sudan J Paediatr. 2022;22(1):36-46. doi: 10.24911/SJP.106-1642444214.
10
Actions of N-acetylcysteine, daptomycin, vancomycin, and linezolid on methicillin-resistant Staphylococcus aureus biofilms in the ventriculoperitoneal shunt infections: an experimental study.N-乙酰半胱氨酸、达托霉素、万古霉素和利奈唑胺对脑室腹腔分流感染中耐甲氧西林金黄色葡萄球菌生物膜的作用:一项实验研究
Chin Neurosurg J. 2022 Jul 5;8(1):15. doi: 10.1186/s41016-022-00284-2.
美国脑积水患儿的住院治疗:利用情况、费用、合并症及死亡情况。
J Neurosurg Pediatr. 2008 Feb;1(2):131-7. doi: 10.3171/PED/2008/1/2/131.
4
Management of shunt infections: a multicenter pilot study.分流感染的管理:一项多中心试点研究。
J Neurosurg. 2006 Sep;105(3 Suppl):177-81. doi: 10.3171/ped.2006.105.3.177.
5
Conservative management of patients with cerebrospinal fluid shunt infections.脑脊液分流感染患者的保守治疗
Neurosurgery. 2006 Apr;58(4):657-65; discussion 657-65. doi: 10.1227/01.NEU.0000204126.54417.46.
6
Cerebrospinal fluid shunt infection: risk factors and long-term follow-up.脑脊液分流感染:危险因素及长期随访
Childs Nerv Syst. 2006 Jul;22(7):692-7. doi: 10.1007/s00381-005-0037-8. Epub 2006 Mar 14.
7
Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.鞘内注射黏菌素与耐多药铜绿假单胞菌分流感染的杀菌作用
Ann Pharmacother. 2005 May;39(5):949-52. doi: 10.1345/aph.1E485. Epub 2005 Apr 5.
8
Pediatric hydrocephalus: current management.小儿脑积水:当前的治疗方法
Neurol Clin. 2003 Nov;21(4):883-95, vii. doi: 10.1016/s0733-8619(03)00016-1.
9
Reflections on shunt infection.关于分流感染的思考。
Pediatr Neurosurg. 2003 Dec;39(6):285-90. doi: 10.1159/000075255.
10
Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience.脑脊液分流术的生存情况及失败原因:一项为期七年的机构经验
Pediatr Neurosurg. 2002 May;36(5):248-55. doi: 10.1159/000058428.